If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.083%)
Open: 485.00
High: 485.00
Low: 485.00
Prev. Close: 485.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Realisation of Investment

7 Dec 2023 07:23

RNS Number : 0138W
B.P. Marsh & Partners PLC
07 December 2023
 

7 December 2023

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Realisation of investment

 Sale of Paladin Holdings Limited, parent company of CBC UK Limited

 

B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses, is pleased to announce the sale of its entire shareholding in Paladin Holdings Limited ("Paladin"), the holding company of CBC UK Limited ("CBC"), subject to certain conditions including regulatory approval being granted.

 

Highlights:

· £41.8m (net of all transaction costs) initial cash consideration expected to be received from the disposal of the Group's 43.8% holding in Paladin on completion, subject to regulatory approval

· Internal rate of return to B.P. Marsh of 45% (inclusive of all income and fees) based on initial consideration

· Repayment to the Group of £5.9m outstanding loans to Paladin

· £11.3m uplift from £30.53m valuation as at 31 July 2023

· Potential for £17.8m further consideration if Paladin achieves defined hurdles

· Initial equity investment of £3.5k

 

Sale of Shareholding in Paladin

 

B.P. Marsh has agreed to sell its shareholding in Paladin, the parent company of CBC, the London-based Insurance Broker, to Specialist Risk Group Limited ("SRG"), one of the fastest growing groups of insurance intermediaries in the UK, subject to regulatory approval. SRG is backed by HGGC, the Californian based mid-market private equity firm.

 

Background to the Investment

 

B.P. Marsh originally invested in Paladin as part of a Management Buy-Out in February 2017, with an initial equity investment of £3.5k for a 35% shareholding. The Company has also supported Paladin with loan funding during this time, and currently has outstanding debt of £5.9m. Since B.P. Marsh's investment, Paladin's EBITDA has grown from a loss of £(50)k in 2016 to a forecast adjusted EBITDA of £10m in FY23. In the year ended 31 January 2023, Paladin contributed £0.9m to the Group's total income from investments.

 

The Transaction

 

Upon completion, the Group expects to receive at least £41.8m in cash (net of all transaction costs) plus repayment in full of its £5.9m loans to Paladin, an aggregate cash receipt of £47.7m. The equity proportion of the initial consideration alone represents an £11.3m uplift (or 37%) on the Group's most recent £30.53m valuation of the investment as at 31 July 2023, underlining our valuation methodology.

 

As well as the initial consideration on completion, the Company will also be entitled to receive its proportion of any net working capital adjustment, expected to be finalised within three months of completion.

 

The Company will then be entitled to receive deferred consideration of up to £17.8m in cash based upon 20% EBITDA growth targets above Paladin's current EBITDA in FY24 and FY25, payable in 2025 and 2026. There is the possibility of further consideration in FY25 should Paladin outperform these growth targets.

 

Jon Newman, the Company's Finance Director and Nominee Director on the Boards of Paladin and CBC, will resign from his roles at Paladin and CBC on completion of the sale.

 

The investment, development and subsequent sale of the Group's holding in Paladin demonstrates B.P. Marsh's established strategy of partnering with entrepreneurial management teams to assist their growth prior to reaching a management-led exit in a time frame that suits all parties.

 

Jon Newman, the Group's Finance Director, commented:

 

"The sale of our stake in Paladin at an expected IRR of 45% at completion with the potential for significant further consideration over the next two years, is testament to our investment strategy and ability to identify opportunities to back successful management teams and to successfully realise value for our shareholders. We believe that there are few, if any, UK investors that could have made this investment, demonstrating the specialist position that B.P. Marsh occupies in the marketplace and the opportunities that this can provide our investors.

 

"It has been an absolute pleasure to work with Andrew Wallas, Rob Cottingham and the whole team at CBC and be a part of the transformational growth since the MBO almost seven years ago. This deal offers an exciting future for both SRG and CBC, and the whole of B.P. Marsh wishes everyone at CBC every success in the future."

 

Andrew Wallas, Chairman of CBC, said:

 

"When Rob Cottingham called me in 2016 to explain the opportunity for a Management Buyout of independent Lloyd's Broker CBC, I contacted B.P. Marsh, who agreed to partner with us very readily. This year is the 50th anniversary of me commencing my career within the Lloyd's market as a junior administrator with Nelson Hurst under the tutelage of Brian Marsh. B.P. Marsh has provided follow on funding and supported us to expand the business by attracting highly experienced, talented and dedicated practitioners.

 

"The B.P. Marsh nominee director on our board, Jon Newman, has provided us with insight, inspiration, wise council and a calming influence which has been invaluable to us as we have developed the business under the leadership of Rob Cottingham. The role and expertise of B.P. Marsh and in particular Jon Newman in helping us to navigate this transaction has been deeply appreciated by both Rob Cottingham and myself."

 

Use of Proceeds

 

Subject to completion, this transaction would increase the Group's current funds to approximately £93.7m after transaction costs and tax. Following the receipt of the Sales proceeds, the Directors will present their plans for the utilisation of this cash to Shareholders.

 

Note

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGRBDDCBGDGXR
Date   Source Headline
11th Jan 20217:00 amRNSInvestee Company Update - Nexus Underwriting
6th Jan 20215:39 pmRNSDirector/PDMR Shareholding
6th Jan 202112:04 pmRNSInvestee Company Update - XPT Group LLC
22nd Dec 20203:27 pmRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestee Company Update – Nexus Underwriting
19th Nov 20207:00 amRNSInvestee Company Update – Lilley Plummer Risks
27th Oct 202010:37 amRNSDirector/PDMR Shareholding
14th Oct 20203:54 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSInterim Results
23rd Sep 20203:01 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSTrading Update
4th Sep 20209:42 amRNSInvestee Company Update: LEBC
25th Aug 202010:36 amRNSInvestee Company Update
14th Aug 202011:41 amRNSDirector/PDMR Shareholding
13th Aug 202010:56 amRNSHolding(s) in Company
12th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSFurther Progress at US Investee Company XPT Group
27th Jul 20204:13 pmRNSDirector/PDMR Shareholding
20th Jul 20205:05 pmRNSResult of AGM
13th Jul 20209:16 amRNSDubai International Financial Centre – EC3 Brokers
30th Jun 20203:21 pmRNSDirector/PDMR Shareholding
29th Jun 20207:00 amRNSInvestment – SAGE Program Underwriters
26th Jun 20203:04 pmRNSNotice of AGM
26th Jun 20209:28 amRNSDirector/PDMR Shareholding
23rd Jun 202012:27 pmRNSTotal Voting Rights
10th Jun 20202:05 pmRNSSecond Price Monitoring Extn
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202011:36 amRNSDirector/PDMR Shareholding
9th Jun 20207:00 amRNSFinal Results
30th Apr 202012:41 pmRNSPortfolio Update
23rd Apr 202010:50 amRNSTotal Voting Rights
23rd Apr 20209:22 amRNSInvestee Company Acquisition
30th Mar 20205:52 pmRNSDirector/PDMR Shareholding
24th Mar 20204:05 pmRNSDirector/PDMR Shareholding
20th Mar 202010:47 amRNSDirector/PDMR Shareholding
13th Mar 20201:52 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSInvestee Company Update
2nd Mar 20204:30 pmRNSDirector/PDMR Shareholding
28th Feb 202010:22 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSInvestee Company Update - Nexus Underwriting
18th Feb 20207:00 amRNSInvestee Company Update - Nexus
13th Feb 20202:29 pmRNSDirector/PDMR Shareholding
5th Feb 20207:00 amRNSTrading Update February 2020
29th Jan 20204:31 pmRNSPDMR and Director Dealings
28th Jan 20204:36 pmRNSPDMR and Director Dealings
28th Jan 20203:51 pmRNSPDMR and Director Dealings
28th Jan 20203:51 pmRNSPDMR and Director Dealings
8th Jan 202011:51 amRNSPDMR and Director Dealings
12th Dec 20194:45 pmRNSPDMR and Director Dealings
11th Dec 20194:15 pmRNSCancellation of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.